Tickers

1. Composite Trajectory Verdict

For this subscription software business, the income statement and cash flow statement carry roughly equal weight as primary drivers of value creation, while the balance sheet reflects the cumulative result of their strength.

Composite Trajectory: Improving

Annual total revenue grew consistently at 16% in both FY2025 ($2.747B) and FY2026 ($3.195B) over FY2024 ($2.364B), with subscription revenue growing 20% then 17% (10-K 2026-01-31, Consolidated Statements of Comprehensive Income). Operating margin expanded from 18.2% (FY2024) to 25.2% (FY2025) to 28.7% (FY2026). Net income rose from $525.7M to $714.1M to $908.9M over the same periods. Operating cash flow grew 20% then 30% annually to $1.415B in FY2026 (10-K 2026-01-31, Consolidated Statements of Cash Flows). The most recent comparable quarter (Q2 FY2027 vs Q2 FY2026) showed 18% revenue growth to $928.0M and 40% operating income growth to $275.0M (10-Q 2026-07-31, Condensed Statements of Operations). Cash and short-term investments increased from $5.15B (Jan 2025) to $6.56B (Jan 2026) to $7.24B (July 2026) with zero interest-bearing debt (10-K 2026-01-31 and 10-Q 2026-07-31, Balance Sheets). All three statements show consistent improvement across the available periods.

2. Red Flags

• G&A expense included a $30.6M litigation settlement charge in the quarter ended July 31, 2025, causing a spike that reversed in the comparable quarter of 2026 (10-Q 2026-07-31, MD&A).
• Effective tax rate rose to 23.9% in FY2026 from 22.3% in FY2025 due to the One Big Beautiful Bill Act (OBBBA) provisions (10-K 2026-01-31, MD&A).
• Accumulated other comprehensive income swung to -$46.1M at July 31, 2026 from +$8.2M at January 31, 2026, reflecting unrealized losses on available-for-sale securities (10-Q 2026-07-31, Consolidated Balance Sheets).
• Deferred revenue declined sequentially from $1.489B at January 31, 2026 to $1.311B at July 31, 2026, consistent with the disclosed seasonal pattern where the first fiscal quarter is the strongest billing period (10-Q 2026-07-31, Balance Sheet; 10-K 2026-01-31, MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Annual total revenue grew 16% in both FY2025 ($2.747B) and FY2026 ($3.195B) over the prior year (10-K 2026-01-31, Consolidated Statements of Comprehensive Income). Subscription revenue grew 20% in FY2025 and 17% in FY2026. Total gross margin expanded from 71.3% (FY2024) to 74.5% (FY2025) to 75.5% (FY2026). Operating margin improved from 18.2% to 25.2% to 28.7% over the same three years. Net income increased from $525.7M to $714.1M to $908.9M. In the most recent comparable quarter (Q2 FY2027 vs Q2 FY2026), total revenue grew 18% to $928.0M, operating income grew 40% to $275.0M, and net income grew 36% to $273.4M (10-Q 2026-07-31, Condensed Statements of Operations). Six-month figures through July 31 show 17% revenue growth and 28% operating income growth year-over-year.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Net cash provided by operating activities grew from $911.3M (FY2024) to $1,090.1M (FY2025, +20%) to $1,415.2M (FY2026, +30%) (10-K 2026-01-31, Consolidated Statements of Cash Flows). For the six months ended July 31, 2026, operating cash flow was $1,365.8M versus $1,115.6M in the prior year period (+22%) (10-Q 2026-07-31, Condensed Statements of Cash Flows). Capital expenditures remained minimal at $29.1M in FY2026 and $20.5M in FY2025, so free cash flow approximates operating cash flow. Cash and short-term investments increased from $5.15B at January 31, 2025 to $6.56B at January 31, 2026 to $7.24B at July 31, 2026 (10-K 2026-01-31 and 10-Q 2026-07-31, Balance Sheets). Financing outflows in FY2026 ($9.3M used) and the first half of FY2027 ($521.8M used) primarily reflect share repurchases ($180M in FY2026, $467M in first half FY2027).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total assets grew from $7.34B (January 2025) to $8.98B (January 2026) to $9.06B (July 2026) (10-K 2026-01-31 and 10-Q 2026-07-31, Consolidated Balance Sheets). Cash and short-term investments rose from $5.15B to $6.56B to $7.24B over the same dates. Accounts receivable grew proportionally with revenue ($1.02B to $1.26B annually; $497M at July 2026, seasonally lower). Deferred revenue increased annually from $1.27B to $1.49B but declined seasonally to $1.31B at July 2026. Total liabilities remained low at $1.51B, $1.76B, and $1.63B respectively, with no interest-bearing debt — only operating lease liabilities. Stockholders' equity increased from $5.83B to $7.21B to $7.43B. Goodwill increased to $493M at July 2026 from $440M due to the Ostro acquisition. Accumulated other comprehensive income turned negative (-$46.1M) at July 2026 from +$8.2M at January 2026 due to unrealized investment losses.

6. Data Gaps

• Quarterly data for Q1 FY2027 (quarter ended April 30, 2026), Q3 FY2026 (quarter ended October 31, 2025), and Q1 FY2026 (quarter ended April 30, 2025) were not provided in the filings text, preventing full quarterly trend analysis.
• Calculated billings and normalized billings metrics are not reported; the company states they are not precise indicators (10-K 2026-01-31, MD&A).
• Net revenue retention rate, customer churn, and customer acquisition cost metrics are not disclosed in the provided filings.
• No debt instruments or debt maturity schedule exists to assess leverage risk; only operating lease liabilities are present.
• The impact of the Ostro acquisition (March 2026) on future periods is not yet reflected beyond initial purchase price allocation (10-K 2026-01-31, Note 17; 10-Q 2026-07-31, Balance Sheet).